상세 보기
Preliminary Results of a Phase 1, Dose-Escalation Study of PRT2527, a Potent and Highly Selective CDK9 Inhibitor, As Monotherapy and in Combination with Zanubrutinib in Patients with Relapsed/Refractory Lymphoid Malignancies
- Lewis, Katharine L.;
- Jurczak, Wojciech;
- Gregory, Gareth P.;
- Tam, Constantine S.;
- Kim, Won Seog;
- 외 15명
Citations
WEB OF SCIENCE
0Citations
SCOPUS
0- 제목
- Preliminary Results of a Phase 1, Dose-Escalation Study of PRT2527, a Potent and Highly Selective CDK9 Inhibitor, As Monotherapy and in Combination with Zanubrutinib in Patients with Relapsed/Refractory Lymphoid Malignancies
- 저자
- Lewis, Katharine L.; Jurczak, Wojciech; Gregory, Gareth P.; Tam, Constantine S.; Kim, Won Seog; Hawkes, Eliza A.; Morschhauser, Franck; Assouline, Sarit E.; Shouse, Geoffrey; Langerbeins, Petra; Tani, Monica; Do, Young Rok; Cheson, Bruce D.; Diefenbach, Catherine S.; Portell, Craig A.; Xavier, Jennifer; Osman, Muhtarjan; Atwal, Siminder K.; Hong, Wan-Jen; Sarkozy, Clementine
- 발행일
- 2024-11-05
- 유형
- Meeting Abstract
- 저널명
- Blood
- 권
- 144
- 페이지
- 4501 ~ 4503